Search Results

Filter
  • 1-10 of  202 results for ""Novelli, G.""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.

Subjects: COVID-19* ; Vaccines* ; Interferon Type I*

  • Source: Science immunology [Sci Immunol] 2023 Dec 22; Vol. 8 (90), pp. eabp8966. Date of Electronic Publication: 2023 Dec 22.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic

Record details

×
Academic Journal

COVID-19 annual update: a narrative review.

  • Authors : Biancolella M; Department of Biology, Tor Vergata University of Rome, 00133, Rome, Italy.; Colona VL

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy; Humans ; SARS-CoV-2/SARS-CoV-2/SARS-CoV-2/genetics

  • Source: Human genomics [Hum Genomics] 2023 Jul 24; Vol. 17 (1), pp. 68. Date of Electronic Publication: 2023 Jul 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101202210 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-7364

Record details

×
Academic Journal

COVID-19: S-Peptide RBD 484-508 Induces IFN-γ T-Cell Response in Naïve-to-Infection and Unvaccinated Subjects with Close Contact with SARS-CoV-2-Positive Patients.

  • Authors : Murdocca M; Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.; Citro G

Subjects: COVID-19*; Humans ; T-Lymphocytes

  • Source: Viruses [Viruses] 2023 Jun 22; Vol. 15 (7). Date of Electronic Publication: 2023 Jun 22.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

×
Academic Journal

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

Subjects: COVID-19* ; Interferon Type I*; Humans

  • Source: Genome medicine [Genome Med] 2023 Apr 05; Vol. 15 (1), pp. 22. Date of Electronic Publication: 2023 Apr 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X

Record details

×
Editorial & Opinion

Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; Myocarditis*/Myocarditis*/Myocarditis*/etiology

  • Source: Journal of clinical immunology [J Clin Immunol] 2022 Oct; Vol. 42 (7), pp. 1354-1359. Date of Electronic Publication: 2022 Oct 08.Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors.

  • Authors : Latini A; Department of Biomedicine and Prevention, Genetics Unit, University of Rome 'Tor Vergata', Rome, Italy.; Vancheri C

Subjects: COVID-19*/COVID-19*/COVID-19*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2022 Oct; Vol. 26 (19), pp. 4940-4948. Date of Electronic Publication: 2022 Sep 08.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

COVID-19 2022 update: transition of the pandemic to the endemic phase.

Subjects: COVID-19* ; Influenza, Human*; Humans

  • Source: Human genomics [Hum Genomics] 2022 Jun 01; Vol. 16 (1), pp. 19. Date of Electronic Publication: 2022 Jun 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101202210 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-7364

Record details

×
Academic Journal

Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies.

  • Authors : Miersch S; The Donnelly Centre, University of Toronto, Toronto, ON, Canada. Electronic address: .; Sharma N

Subjects: COVID-19* ; SARS-CoV-2*; Antibodies, Neutralizing SARS-CoV-2 variants

  • Source: Cell reports [Cell Rep] 2022 May 31; Vol. 39 (9), pp. 110905. Date of Electronic Publication: 2022 May 16.Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

COVID-19 and Molecular Genetics.

  • Authors : Novelli G; Department of Biomedicine and Prevention, Tor Vergata University of Rome, 00133 Rome, Italy.; Biancolella M

Subjects: COVID-19*/COVID-19*/COVID-19*/genetics; Humans ; Molecular Biology

  • Source: Genes [Genes (Basel)] 2022 Apr 12; Vol. 13 (4). Date of Electronic Publication: 2022 Apr 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101551097 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4425

Record details

×
Academic Journal

A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection.

Subjects: Genetic Predisposition to Disease*; COVID-19/COVID-19/COVID-19/*genetics ; Disease Resistance/Disease Resistance/Disease Resistance/*genetics

  • Source: Nature immunology [Nat Immunol] 2022 Feb; Vol. 23 (2), pp. 159-164. Date of Electronic Publication: 2021 Oct 18.Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  202 results for ""Novelli, G.""